新冠病毒给免疫系统带来了一个谜。 - Suppr

Suppr

超能文献

COVID-19 poses a riddle for the immune system.

作者信息

Perlman Stanley

出版信息

Nature. 2020 Aug;584(7821):345-346. doi: 10.1038/d41586-020-02379-1.

DOI:10.1038/d41586-020-02379-1

PMID:32807916

Abstract

摘要

相似文献

COVID-19 poses a riddle for the immune system.新冠病毒给免疫系统带来了一个谜。

Nature. 2020 Aug;584(7821):345-346. doi: 10.1038/d41586-020-02379-1.

Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.新型冠状病毒肺炎患者肺部的组织病理学变化及严重急性呼吸综合征冠状病毒2免疫染色

Ann Intern Med. 2020 Aug 18;173(4):324. doi: 10.7326/L20-0895.

Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.一名新冠肺炎患者肺部的组织病理学变化及严重急性呼吸综合征冠状病毒2免疫染色

Ann Intern Med. 2020 Aug 18;173(4):323-324. doi: 10.7326/L20-0894.

Research Response to SARS-CoV-2/COVID-19.对严重急性呼吸综合征冠状病毒2/2019冠状病毒病的研究应对措施

Mayo Clin Proc. 2020 Sep;95(9S):S52-S55. doi: 10.1016/j.mayocp.2020.06.048. Epub 2020 Jul 7.

COVID-19: science must not be the boy who cried wolf.新冠疫情：科学绝不能成为喊狼来了的那个孩子。

J Epidemiol Community Health. 2020 Aug;74(8):676. doi: 10.1136/jech-2020-214448. Epub 2020 May 20.

Avoidable Waste of Research on Coronavirus Disease 2019 (COVID-19).2019冠状病毒病（COVID-19）研究中的可避免浪费

Obstet Gynecol. 2020 Jul;136(1):191. doi: 10.1097/AOG.0000000000003978.

New view on older adults with COVID-19: comments on "SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes".关于新冠肺炎老年患者的新观点：对《老年人中的SARS-CoV-2和新冠肺炎：关于发病机制、免疫反应及预后我们可能了解到的情况》的评论

Geroscience. 2020 Oct;42(5):1225-1227. doi: 10.1007/s11357-020-00232-x. Epub 2020 Jul 24.

The value of serology testing to manage SARS-CoV-2 infections.血清学检测在管理 SARS-CoV-2 感染中的价值。

Eur Respir J. 2020 Aug 27;56(2). doi: 10.1183/13993003.02411-2020. Print 2020 Aug.

Rhabdomyolysis as Potential Late Complication Associated with COVID-19.横纹肌溶解症作为与2019冠状病毒病相关的潜在晚期并发症

Emerg Infect Dis. 2020 Oct;26(10):2535. doi: 10.3201/eid2610.202225. Epub 2020 Jul 2.

Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2.SARS-CoV-2 引起的 COVID-19 肺炎患者的死亡预测因子。

Eur Respir J. 2020 Sep 24;56(3). doi: 10.1183/13993003.02961-2020. Print 2020 Sep.

引用本文的文献

Inflammatory and Coagulation Marker Changes in PMX-DHP-Treated COVID-19 Patients.接受PMX-DHP治疗的COVID-19患者的炎症和凝血标志物变化

Cureus. 2025 Feb 10;17(2):e78836. doi: 10.7759/cureus.78836. eCollection 2025 Feb.

The exploration of glucocorticoid pathway based on disease severity in COVID-19 patients.基于COVID-19患者疾病严重程度对糖皮质激素途径的探索。

Heliyon. 2023 Dec 10;10(1):e23579. doi: 10.1016/j.heliyon.2023.e23579. eCollection 2024 Jan 15.

Recognition of Differentially Expressed Molecular Signatures and Pathways Associated with COVID-19 Poor Prognosis in Glioblastoma Patients.识别与 COVID-19 不良预后相关的胶质母细胞瘤患者差异表达的分子特征和途径。

Int J Mol Sci. 2023 Feb 10;24(4):3562. doi: 10.3390/ijms24043562.

Immuno-Modulatory Effects of Dexamethasone in Severe COVID-19-A Swedish Cohort Study.地塞米松在重症新型冠状病毒肺炎中的免疫调节作用——一项瑞典队列研究

Biomedicines. 2023 Jan 9;11(1):164. doi: 10.3390/biomedicines11010164.

Publication trends of research on COVID-19 and host immune response: A bibliometric analysis.COVID-19 与宿主免疫反应研究的发表趋势：文献计量分析。

Front Public Health. 2022 Aug 8;10:939053. doi: 10.3389/fpubh.2022.939053. eCollection 2022.

Treatment of COVID-19 Pneumonia and Acute Respiratory Distress With Ramatroban, a Thromboxane A and Prostaglandin D Receptor Antagonist: A Four-Patient Case Series Report.用血栓素A和前列腺素D受体拮抗剂雷马曲班治疗新型冠状病毒肺炎和急性呼吸窘迫：四例病例系列报告

Front Pharmacol. 2022 Jul 22;13:904020. doi: 10.3389/fphar.2022.904020. eCollection 2022.

Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath.拉马曲班用于 COVID-19 的化学预防和治疗：大卫对战歌利亚。

Expert Opin Ther Targets. 2022 Jan;26(1):13-28. doi: 10.1080/14728222.2022.2031975. Epub 2022 Feb 22.

Pathogenesis of Respiratory Viral and Fungal Coinfections.呼吸道病毒和真菌合并感染的发病机制。

Clin Microbiol Rev. 2022 Jan 19;35(1):e0009421. doi: 10.1128/CMR.00094-21. Epub 2021 Nov 17.

Targeting the PI3K/Akt/mTOR pathway: A therapeutic strategy in COVID-19 patients.针对 PI3K/Akt/mTOR 通路：COVID-19 患者的一种治疗策略。

Immunol Lett. 2021 Dec;240:1-8. doi: 10.1016/j.imlet.2021.09.005. Epub 2021 Sep 23.

SARS-CoV-2: Understanding the Transcriptional Regulation of ACE2 and TMPRSS2 and the Role of Single Nucleotide Polymorphism (SNP) at Codon 72 of p53 in the Innate Immune Response against Virus Infection.严重急性呼吸综合征冠状病毒 2 型：了解 ACE2 和 TMPRSS2 的转录调控，以及 p53 密码子 72 处单核苷酸多态性（SNP）在固有免疫反应对病毒感染中的作用。

Int J Mol Sci. 2021 Aug 12;22(16):8660. doi: 10.3390/ijms22168660.

本文引用的文献

Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.深度免疫剖析 COVID-19 患者，揭示具有治疗意义的不同免疫类型。

Science. 2020 Sep 4;369(6508). doi: 10.1126/science.abc8511. Epub 2020 Jul 15.

Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.COVID-19 和流感的免疫表型分析突出了 I 型干扰素在 COVID-19 重症发展中的作用。

Sci Immunol. 2020 Jul 10;5(49). doi: 10.1126/sciimmunol.abd1554.

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.无症状 SARS-CoV-2 感染的临床和免疫学评估。

Nat Med. 2020 Aug;26(8):1200-1204. doi: 10.1038/s41591-020-0965-6. Epub 2020 Jun 18.

Viral and host factors related to the clinical outcome of COVID-19.与 COVID-19 临床结果相关的病毒和宿主因素。

Nature. 2020 Jul;583(7816):437-440. doi: 10.1038/s41586-020-2355-0. Epub 2020 May 20.

Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients.COVID-19 患者呼吸道中的先天免疫反应增强。

Cell Host Microbe. 2020 Jun 10;27(6):883-890.e2. doi: 10.1016/j.chom.2020.04.017. Epub 2020 May 4.

COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome.COVID-19：一种新病毒，但熟悉的受体和细胞因子释放综合征。

Immunity. 2020 May 19;52(5):731-733. doi: 10.1016/j.immuni.2020.04.003. Epub 2020 Apr 22.

Cytokine release syndrome in severe COVID-19.重症新型冠状病毒肺炎中的细胞因子释放综合征

Science. 2020 May 1;368(6490):473-474. doi: 10.1126/science.abb8925. Epub 2020 Apr 17.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验